OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
18.67
-0.55 (-2.86%)
Mar 3, 2026, 4:00 PM EST - Market closed
OrthoPediatrics Stock Forecast
Stock Price Forecast
The 9 analysts that cover OrthoPediatrics stock have a consensus rating of "Strong Buy" and an average price target of $24.67, which forecasts a 32.14% increase in the stock price over the next year. The lowest target is $20 and the highest is $34.
Price Target: $24.67 (+32.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OrthoPediatrics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | +7.12% | Mar 2, 2026 |
| Needham | Needham | Strong Buy Maintains $26 → $30 | Strong Buy | Maintains | $26 → $30 | +60.69% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +28.55% | Feb 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +23.19% | Jan 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +28.55% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
269.60M
from 236.35M
Increased by 14.07%
Revenue Next Year
301.55M
from 269.60M
Increased by 11.85%
EPS This Year
-1.16
from -1.69
EPS Next Year
-0.77
from -1.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 278.3M | 313.7M | |||
| Avg | 269.6M | 301.6M | |||
| Low | 258.7M | 288.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.7% | 16.4% | |||
| Avg | 14.1% | 11.9% | |||
| Low | 9.5% | 7.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.04 | -0.32 | |||
| Avg | -1.16 | -0.77 | |||
| Low | -1.48 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.